dichloroacetic acid has been researched along with Angiogenesis, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carmine-Simmen, K; Dromparis, P; Gurtu, V; Kinnaird, A; Lewis, JD; Michelakis, ED; Moore, R; Paulin, R; Pink, DB; Saleme, B; Stenson, T; Sutendra, G; Watson, K; Zervopoulos, S | 1 |
Abdulkarim, B; Dromparis, P; Fulton, D; Gammer, TL; Haromy, A; Mackey, JR; Maguire, C; McMurtry, MS; Michelakis, ED; Niven, E; Petruk, KC; Sutendra, G; Webster, L | 1 |
2 other study(ies) available for dichloroacetic acid and Angiogenesis, Pathologic
Article | Year |
---|---|
Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Male; Mice, Nude; Mitochondria; Neovascularization, Pathologic; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Signal Transduction; Time Factors; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
Metabolic modulation of glioblastoma with dichloroacetate.
Topics: Adult; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dichloroacetic Acid; Female; Glioblastoma; Humans; In Vitro Techniques; Male; Membrane Potential, Mitochondrial; Middle Aged; Mitochondria; Neoplastic Stem Cells; Neovascularization, Pathologic; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Reactive Oxygen Species | 2010 |